---
layout: default
title: "Gemcitabine 相關新聞"
parent: 健康新聞
nav_exclude: true
permalink: /news/gemcitabine/
---

# Gemcitabine 相關新聞

[← 返回新聞總覽]({{ '/news/' | relative_url }})

---

<div class="drug-info-card">
<strong>藥物資訊</strong>
<ul>
<li><strong>原適應症</strong>：轉移性大腸直腸癌</li>
<li><strong>證據等級</strong>：L2</li>
<li><strong>預測適應症</strong>（10 個）：<ul>
<li>female breast carcinoma（100.0%）</li>
<li>rectum mucinous adenocarcinoma（99.8%）</li>
<li>colon mucinous adenocarcinoma（99.8%）</li>
<li>endometrial mixed adenocarcinoma（99.8%）</li>
<li>villoglandular endometrial endometrioid adenocarcinoma（99.8%）</li>
<li>endometrial mucinous adenocarcinoma（99.8%）</li>
<li>cervical mucinous adenocarcinoma（99.8%）</li>
<li>gallbladder mucinous adenocarcinoma（99.8%）</li>
<li>rete ovarii adenocarcinoma（99.7%）</li>
<li>secretory uterine corpus endometrioid adenocarcinoma（99.7%）</li>
</ul></li>
</ul>
<p><a href="{{ '/drugs/gemcitabine/' | relative_url }}">查看完整藥物報告 →</a></p>
</div>

## 相關新聞（1 則）

### [盡快參加大腸癌篩查計劃及早識別守護健康- 大文號](https://news.google.com/rss/articles/CBMicEFVX3lxTE8tMHhmMnF2Ym1Hay12RTN0eV9aWWplaXk1MHZIQ2N1UXU4aDJhVDZxcUFIbzdTMi1mUmc3RnNSUnRRSzA3M05ZXzdrUHV2S2dzOGJlNUEtd3hoNXgxSDdEazBHMUFtQ2dGLS0zVGpNQnU?oc=5)

2026-02-19

來源：[大公文匯網](https://news.google.com/rss/articles/CBMicEFVX3lxTE8tMHhmMnF2Ym1Hay12RTN0eV9aWWplaXk1MHZIQ2N1UXU4aDJhVDZxcUFIbzdTMi1mUmc3RnNSUnRRSzA3M05ZXzdrUHV2S2dzOGJlNUEtd3hoNXgxSDdEazBHMUFtQ2dGLS0zVGpNQnU?oc=5)

---


<div class="disclaimer">
<strong>免責聲明</strong>：本頁新聞由系統自動收集，僅供研究參考，不構成醫療建議。
</div>
